Skip to content

Supplier News

Viviscal Extra Strength makes debut

Viviscal has introduced an extra strength version of its hair growth dietary supplement for men and women. The company said Tuesday that Viviscal Extra Strength has 50% more AminoMar, the active ingredient in Viviscal products.

Contac product lineup gets a face-lift

Contac cold and flu medicine is hitting shelves with a new look for the new year. Contac’s new look is designed to more clearly designate the brand, SKU and symptom relief. Meda Consumer Healthcare enlisted partner Little Big Brands to lead a redesign of the venerable cold medicine brand and give

Ther-Rx, Perrigo ship Gynazole-1 cream

Ther-Rx Corp. and Perrigo Co. have released Gynazole-1 vaginal cream to pharmacies for prescribing. A subsidiary of K-V Pharmaceutical Co., Ther-Rx said Thursday that Gynazole-1 (butoconazole nitrate vaginal cream 2%) is now available at national and regional retail pharmacy chains nationwide.

Watson acquires Uteron Pharma

Watson Pharmaceuticals Inc. has acquired Uteron Pharma SA, a Belgium-based developer of women’s health products. Watson said Wednesday that it has completed the deal, which includes an up-front cash payment of $150 million and up to $155 million in potential future milestone payments.

Pampers adds bigger sizes for Swaddlers

Pampers is enabling toddlers to stay in their Swaddlers diapers longer. The Procter & Gamble diaper brand said Wednesday that it’s launching Pampers Swaddlers, previously available only through size 3 (16 to 28 lbs.), in sizes 4 and 5 at Target stores nationwide.

Allergan to buy MAP Pharmaceuticals

Allergan Inc. plans to acquire MAP Pharmaceuticals Inc. in a deal valued at about $958 million. The drug companies said Tuesday evening that the transaction will be done through a cash tender offer followed by a second-step merger. The per-share cash offer price represents a 60% premium over

Lupin gets OK for Lutera generic

Lupin Ltd. is set to market levonorgestrel and ethinyl estradiol tablets (0.1 mg/0.02 mg), an oral contraceptive, in the United States. The India-based drug maker said Tuesday that its subsidiary Lupin Pharmaceuticals Inc.